(S)-4-fluoro-N-((1-(4-(hydroxyamino)-1-(naphthalen-2-yl)-4-oxobutan-2-yl)-1H-1,2,3-triazol-4-yl)methyl)benzamide

ID: ALA5281900

Max Phase: Preclinical

Molecular Formula: C24H22FN5O3

Molecular Weight: 447.47

Names and Identifiers

Canonical SMILES:  O=C(C[C@H](Cc1ccc2ccccc2c1)n1cc(CNC(=O)c2ccc(F)cc2)nn1)NO

Standard InChI:  InChI=1S/C24H22FN5O3/c25-20-9-7-18(8-10-20)24(32)26-14-21-15-30(29-27-21)22(13-23(31)28-33)12-16-5-6-17-3-1-2-4-19(17)11-16/h1-11,15,22,33H,12-14H2,(H,26,32)(H,28,31)/t22-/m0/s1

Standard InChI Key:  RASCFMYPAZDCKQ-QFIPXVFZSA-N

Molfile:  

 
     RDKit          2D

 33 36  0  0  0  0  0  0  0  0999 V2000
    0.5401   -1.0884    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1272   -0.6035    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.1276    0.1811    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.9526    0.1811    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.2075   -0.6035    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.5401   -1.9135    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2547   -2.3260    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1744   -2.3260    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.9692   -1.9135    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.8889   -1.9135    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.6035   -2.3260    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -2.3181   -1.9135    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.8889   -1.0884    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.2849    0.8956    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1100    0.8956    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.5225    1.6102    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.3476    1.6102    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1100    2.3248    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -2.7604    0.8957    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.5830    0.8964    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.9958    1.6113    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.5866    2.3231    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.7620    2.3278    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.8209    1.6113    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    1.9695   -1.0883    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.6823   -0.6777    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.3971   -1.0904    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.3987   -1.9113    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.6869   -2.3278    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.1054   -0.6802    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.8175   -1.0892    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.8209   -1.9061    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.1136   -2.3220    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  2  0
  3  4  1  0
  4  5  2  0
  5  1  1  0
  1  6  1  0
  6  7  1  1
  6  8  1  0
  7  9  1  0
  8 10  1  0
 10 11  1  0
 11 12  1  0
 10 13  2  0
  3 14  1  0
 14 15  1  0
 15 16  1  0
 16 17  1  0
 16 18  2  0
 19 17  2  0
 20 19  1  0
 21 20  2  0
 22 21  1  0
 23 22  2  0
 17 23  1  0
 21 24  1  0
 25  9  2  0
 26 25  1  0
 27 26  2  0
 28 27  1  0
 29 28  2  0
  9 29  1  0
 27 30  1  0
 31 30  2  0
 32 31  1  0
 33 32  2  0
 28 33  1  0
M  END

Alternative Forms

1. Parent:

   

   ALA5281900

   ---

Molecule Features

Natural Product: No

Oral: No

Chemical Probe: No

Parenteral: No

Molecule Type:

Topical: No

First In Class: No

Black Box: No

Chirality: No

Availability: No

Prodrug: No

Calculated Properties

Molecular Weight: 447.47

Molecular Weight (Monoisotopic): 447.1707

AlogP: 3.18

#Rotatable Bonds: 8

Polar Surface Area: 109.14

Molecular Species: NEUTRAL

HBA: 6

HBD: 3

#RO5 Violations: ┄

HBA (Lipinski): 8

HBD (Lipinski): 3

#RO5 Violations (Lipinski): ┄

CX Acidic pKa: 8.89

CX Basic pKa: 0.18

CX LogP: 3.01

CX LogD: 3.00

Aromatic Rings: 4

Heavy Atoms: 33

QED Weighted: 0.28

Np Likeness Score: -1.14

References

1. Legru A, Verdirosa F, Vo-Hoang Y, Tassone G, Vascon F, Thomas CA, Sannio F, Corsica G, Benvenuti M, Feller G, Coulon R, Marcoccia F, Devente SR, Bouajila E, Piveteau C, Leroux F, Deprez-Poulain R, Deprez B, Licznar-Fajardo P, Crowder MW, Cendron L, Pozzi C, Mangani S, Docquier JD, Hernandez JF, Gavara L..  (2022)  Optimization of 1,2,4-Triazole-3-thiones toward Broad-Spectrum Metallo-β-lactamase Inhibitors Showing Potent Synergistic Activity on VIM- and NDM-1-Producing Clinical Isolates.,  65  (24.0): [PMID:36450011] [10.1021/acs.jmedchem.2c01257]

Source

Source(1):

• Scientific Literature